SCHEMBL9153271

SCHEMBL9153271

O=C(CCCCc1c[nH]c2ccccc12)OCc1ccccc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.67
CYP1A2 P05177 1/20 0.67
CYP3A4 P08684 1/20 0.67
CYP2D6 P10635 1/20 0.67
CYP2C9 P11712 1/20 0.67
CYP2C19 P33261 1/20 0.67
ALDH1A1 P00352 4/20 0.65
MEN1 O00255 4/20 0.60
KMT2A Q03164 4/20 0.60
LMNA P02545 3/20 0.60
KDM4E B2RXH2 1/20 0.59
HPGD P15428 1/20 0.59
TSHR P16473 1/20 0.59
MAPT P10636 5/20 0.54
TP53 P04637 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
TDP1 Q9NUW8 2/20 0.53
NMBR P28336 1/20 0.53
CDK4 P11802 1/20 0.52
MC4R P32245 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9153580 0.99 SMN1; SMN2 (0.66) SMN1; SMN2CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL9149723 0.96 SMN1; SMN2 (0.73) SMN1; SMN2CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL4071928 0.91 LMNA (0.70) SMN1; SMN2CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL7399266 0.85 SMN1; SMN2 (0.92) SMN1; SMN2CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL6100777 0.83 MEN1 (0.74) SMN1; SMN2CYP1A2CYP3A4CYP2C19ALDH1A1
SCHEMBL9155017 0.82 CYP1A2 (0.55) SMN1; SMN2CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL9148446 0.82 CYP1A2 (0.70) SMN1; SMN2CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL2380211 0.81 SMN1; SMN2 (0.66) SMN1; SMN2CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL8960012 0.81 ADAM17 (0.58) SMN1; SMN2CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL22426758 0.81 TACR1 (0.60) SMN1; SMN2CYP1A2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0516849-B1 INDOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 1995-01-25 EP disclosed
US-5283251-A Testosterone 5a-reductase inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-02-01 US disclosed
WO-1991013060-A1 INDOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-09-05 WO disclosed